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A group of integral membrane proteins, known as C-tail
 
anchored, is deﬁned by the presence of a cytosolic NH
 
2
 
-
 
terminal domain that is anchored to the phospholipid
bilayer by a single segment of hydrophobic amino acids
close to the COOH terminus. The mode of insertion into
membranes of these proteins, many of which play key
roles in fundamental intracellular processes, is obligatorily
posttranslational, is highly speciﬁc, and may be subject to
regulatory processes that modulate the protein’s function.
Although recent work has elucidated structural features in
the tail region that determine selection of the correct target
membrane, the molecular machinery involved in inter-
preting this information, and in modulating tail-anchored
protein localization, has not been identiﬁed yet.
Introduction
 
Approximately 30 years ago, the signal hypothesis provided
a conceptual basis that led to the identification of a limited
number of molecular machines that direct groups of proteins
to shared locations within the cell (for review see Blobel,
2000). In addition, however, investigations during the past
years have revealed the existence of proteins that reach their
target organelle by unconventional and poorly understood
mechanisms. Among these, because of the variety of their
locations and functions (Table I), tail-anchored (TA)* proteins
have recently received a good deal of interest.
TA proteins constitute a class of integral membrane proteins
that are held in the phospholipid bilayer by a single stretch
of hydrophobic amino acids close to the COOH terminus,
 
the entire functional NH
 
2
 
-terminal portion facing the cytosol.
They are found on essentially all membranes abutting the
cytosol, where they carry out a variety of enzymatic and reg-
ulatory roles in cellular metabolism, in protein localization,
and in membrane traffic (see Table I). Two examples of TA
proteins that play central roles in cell physiology are soluble
 
N
 
-ethylmaleimide–sensitive factor attachment protein receptors
(SNAREs; for review see Chen and Scheller, 2001) and Bcl-2
family members (for review see Cory and Adams, 2002). In
both these examples, each protein’s function—targeted
membrane fusion or regulation of apoptosis, respectively—is
inextricably linked to its specific localization. Thus, under-
standing the targeting and insertion mechanisms of these
proteins and the underlying regulation is an issue with wide
implications for cell biology.
 
TA proteins lack an NH
 
2
 
-terminal signal sequence, and
their membrane-interacting region is so close to the COOH
terminus that it emerges from the ribosome only upon ter-
mination of translation. This hydrophobic region is, therefore,
unlikely to interact with signal recognition particle (SRP),
which binds signal peptides or signal anchors only as long as
they are part of a nascent polypeptide chain. Thus, TA pro-
teins must reach their target membranes, including the ER,
 
posttranslationally, and this biosynthetic route is what
distinguishes them from classical type II membrane proteins
(defined as proteins having a single transmembrane domain
(TMD) with N-cytosolic, C-exoplasmic orientation), which
are delivered to the ER by the SRP-dependent cotranslational
pathway (Fig. 1). By this biosynthetic criterion then—and
 
considering that the last 
 
 
 
40 amino acids of the nascent
chain are sequestered within the eukaryotic large ribosomal
subunit (Blobel and Sabatini, 1970)—TA proteins should
be considered as such if the membrane-interacting domain is
followed by no more than 
 
 
 
30 residues. For borderline
cases, a more rigorous criterion would be based on the exper-
imental assessment of lack of SRP interaction.
Because of the small number of polar residues down-
stream to the hydrophobic domain, it was initially difficult
to verify whether or not TA proteins actually span the bilayer,
so that their exact topology remained controversial for a long
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time (Kutay et al., 1993). This difficulty was subsequently
overcome by the use of recombinant TA proteins with
N-glycosylation sites engineered to the extreme COOH-ter-
minal polar region (Kutay et al., 1995; Masaki et al., 1996;
Honsho et al., 1998; Pedrazzini et al., 2000). Glycosylation
of these COOH-terminal tags within the ER lumen occurs
in vivo as well as in cell-free translation systems to which mi-
crosomes are added after completion of polypeptide synthe-
sis, formally demonstrating that TA proteins can translocate
their COOH terminus across the bilayer and that this trans-
location occurs posttranslationally (Kutay et al., 1995; Ped-
razzini et al., 2000).
Much of the research on TA protein biosynthesis of the
past few years has highlighted the importance of the tail re-
gion in the initial targeting from the cytosol to membranes,
in the subsequent trafficking within the secretory pathway
 
and, in some cases, in directly influencing the protein’s func-
tion as well. It is worth emphasizing that, because each TA
protein is equipped with its own characteristic tail, this re-
gion has much more complex and diversified roles than
those of the simple lipid anchors of fatty acylated and isopre-
nylated proteins.
Despite the recent progress, the fundamental question of
the nature of the cellular machinery involved in TA protein
insertion into membranes has not been answered yet. In this
review, we will give a brief account of what we have learned
about TA protein trafficking over the past few years, to then
discuss the major unanswered questions as well as novel as-
pects of regulation of this class of proteins.
 
Tail-anchored proteins insert into a limited number of 
intracellular membranes and reach destinations within 
the secretory pathway by membrane traffic
 
Although results from early in vitro studies suggested that at
least some TA proteins (e.g., cytochrome b[5]) could associ-
ate nonspecifically with any membrane, it is now clear that,
in vivo
 
,
 
 TA proteins insert into a limited number of intracel-
lular membranes. Indeed, to reach compartments of the
secretory pathway, TA proteins are first inserted into the ER
and then delivered to their final destination by vesicular
transport (Jäntti et al., 1994; Kutay et al., 1995; Linstedt et
al., 1995; Pedrazzini et al., 1996). Likewise, it appears that
also peroxisomal TA proteins reach the peroxisome after in-
sertion into the ER (Elgersma et al., 1997) or into a special-
ized domain thereof (Mullen and Trelease, 2000). In con-
trast, TA proteins destined for the mitochondrial outer
membrane (MOM) and the chloroplast envelope are tar-
geted directly from the cytosol (Borgese et al., 2001; unpub-
lished data). Thus, upon release from the ribosome, TA pro-
teins must discriminate only between the ER and the MOM
(and the plastid surface in plants).
Experiments with chimaeras between the tail of MOM-
directed proteins and the cytosolic region of ER-directed pro-
teins or soluble reporters have demonstrated that the features
determining discrimination between the MOM and the ER
are generally contained in the COOH-terminal tail (Nguyen
 
Table I. 
 
Different functions and localizations of TA proteins
Function Examples Localization
Enzymatic
 
Cytochrome b(5)
MOM isoform of cytochrome b(5)
Heme oxygenase I and II
UBC6
ER
MOM
ER
ER
 
Protein localization
 
Translocation Sec61
 
 
 
, Sec61
 
 
 
TOM5, TOM6
Pex15p
ER
MOM
Peroxisomes
Adaptors OMP25 MOM
 
Vesicular traffic
 
SNARE proteins Target SNAREs (Syntaxins)
Vesicular SNAREs (e.g., Synaptobrevins)
Target membranes for vesicular fusion
Tethering proteins Giantin Transport vesicles
Golgi complex
 
Regulation of apoptosis (Bcl-2 family
 
) Bcl-2
Bcl-X
 
L
 
Bax
MOM and ER
MOM
Cystol and MOM
 
Constituent of viral envelope
 
Us9 protein of 
 
  
 
herpes viruses Trans-Golgi network
Figure 1. Membrane insertion of tail-anchored proteins occurs 
after release from the ribosome. The figure illustrates the fundamental 
difference between the biosynthesis of a classical type II membrane 
protein (left) and that of a C-tail–anchored protein (right). For type II 
proteins, the signal anchor (red) emerges from the ribosome before 
termination of translation, so that it can interact with SRP (brown). 
For TA proteins, the hydrophobic membrane interacting sequence 
(red) is still sequestered within the ribosome when the stop codon is 
reached, so that it never becomes available to SRP.T
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et al., 1993; De Silvestris et al., 1995; Isenmann et al., 1998;
Nemoto and De Camilli, 1999) (Fig. 2). In MOM-targeted
proteins, this region is often characterized by a rather short
TMD (
 
 
 
20 residues), flanked by basic amino acids (Fig. 2
A). Increasing the length of the TMD or decreasing the posi-
tive charge of the flanking regions has revealed that these
features are indeed important for mitochondrial targeting
(Kuroda et al., 1998; Isenmann et al., 1998; Borgese et al.,
2001; Motz et al., 2002; Kaufmann et al., 2003). On the
other hand, there are exceptions to the short TMD rule, since
some MOM-directed TA proteins have membrane anchors
of considerable length and hydrophobicity (e.g., Bax, a mem-
ber of the Bcl-2 family), suggesting that more subtle sequence
information in this region may sometimes be involved in tar-
geting. Finally, interactions of the cytosolic domain may in
some cases play an important role, as recently reported for
Bcl-2 (Shirane and Nakayma, 2003).
TA proteins without specific targeting information for
the MOM are inserted into the ER, which is able to ac-
cept TMDs of different lengths and sequence followed by
COOH-terminal polar regions of varying size and charge
(Fig. 2 B and C). MOM-directed proteins mutated to have a
longer TMD or less positive charges in the flanking regions
are rerouted to the ER. Likewise, TA proteins with artificial
TMDs, consisting of repeated leucines or repetitions of
strings of a few hydrophobic aminoacids, are also inserted ef-
ficiently (Whitley et al., 1996; Yang et al., 1997; Honsho et
al., 1998). From these observations, it appears likely that the
ER is the default destination for TA proteins (but see also
Kim et al., 1999).
The permissivity of the ER for TA protein insertion com-
bined with the fact that the targeting information for the
MOM is not contained in a discrete signal, but rather ap-
pears to be the result of the summation of two continuously
distributed physicochemical variables (TMD length and de-
gree of flanking positive charge), has the important conse-
quence that proteins with weak MOM targeting features
may be delivered to both the ER and the MOM (Fig. 2 D).
As discussed in the last section of this review, such dual tar-
geting may be subject to regulation with important func-
tional implications.
Once inserted in the ER, a TA protein will either be re-
tained there or transported to alternative final destinations.
In these sorting processes, the tail region, again, plays an im-
portant role. A positively charged lumenal sequence appears
to determine transport to peroxisomes (Elgersma et al.,
1997; Mullen and Trelease, 2000). Sorting along the secre-
tory pathway is instead strongly influenced by the physico-
chemical properties of the TMD. For a number of TA pro-
teins, residence in the ER requires a short and moderately
hydrophobic membrane anchor, which may determine both
slow entry into transport vesicles and retrieval from the early
Golgi (Pedrazzini et al., 2000). Lengthening the TMD of
cytochrome b(5) (Pedrazzini et al., 1996), ubiquitin conju-
gating enzyme 6 (UBC6; Yang et al., 1997), or the ER
SNARE Ufe1p (Rayner and Pelham, 1997) results in the es-
cape of these proteins from the ER and their transport down
the secretory pathway. A systematic investigation of the
properties of the TMD of cytochrome b(5) required for ER
residence revealed that moderate hydrophobicity, rather
than length, is the crucial feature (Bulbarelli et al., 2002).
TMD length or hydrophobicity may also influence further
sorting of TA proteins along the secretory pathway (e.g.,
Reggiori et al., 2000).
In addition to simple physicochemical characteristics, se-
quence-specific features of the TMD may also be involved in
sorting of TA proteins within the secretory pathway. An ex-
ample is provided by the target SNAREs Syntaxins 3 and 4,
which localize respectively to the apical and basolateral
plasma membrane of polarized epithelial cells (Low et al.,
1996). The hydropathy profiles of the tail region of the 2
Syntaxins are similar, yet experiments with GFP fusion pro-
teins suggest that the TMDs do play a role in determining
the polarized distribution of these TA proteins (Bulbarelli et
al., 2002). Sequence-specific information in the TMD may
also be important for TA protein function, as is apparently
the case for SNAREs (Rohde et al., 2003).
Although the TMD plays a key role in TA protein traf-
ficking, the cytosolic domain, in a less generalizable fashion,
also often contributes to their sorting and finetunes their
distribution within the secretory pathway. This appears to
be the case for the Golgi-localized TA proteins studied so far
(Linstedt et al., 1995; Misumi et al., 2001; Bulbarelli et al.,
2002). Likewise, the determinants responsible for SNARE
trafficking, which frequently involves regulated recycling be-
tween two or more compartments, reside both in the TMD
and in the cytosolic domain (Joglekar et al., 2003; and refer-
ences therein).
The role of the TMD in membrane protein trafficking is,
of course, not limited to TA proteins (Bulbarelli et al.,
2002). However, in the case of multidomain proteins, its
contribution is often obscured by the presence of multi-
Figure 2. Features that determine specific targeting of tail-anchored 
proteins to the mitochondrial outer membrane (MOM) or ER. The 
cytosolic domains of the four proteins A–D are shown as a gray 
irregular form, whereas the the color of the COOH-terminal tail is 
matched to that of the corresponding target membrane. The trans-
membrane domain is shown as a zig-zag line. A short transmembrane 
domain, flanked on both sides by positively charged residues, deter-
mines targeting to the MOM (A). Loss of either of these features 
results in targeting to the ER (B and C). Proteins bearing tails with 
intermediate features (purple), i.e., a slightly lengthened hydrophobic 
domain and/or reduced positive charge, may be delivered to both 
the MOM and the ER (D). Targeting and insertion are in some cases 
subject to regulation (see text for details).T
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ple sorting determinants, located in different parts of the
polypeptide. TA proteins, because of their simplicity, and
because of the nearly complete absence of a lumenal do-
main, provide useful models for the investigation of the mo-
lecular basis of TMD-dependent sorting. The use of suitable
TA reporter constructs, containing a neutral cytosolic do-
main devoid of sorting information, should hopefully lead
to an understanding of the mechanism through which
TMDs exert their effects, whether by interactions with other
proteins, with bilayer lipids, or with both these classes of
molecules.
 
What is the nature of the cellular machinery involved 
in TA protein targeting and insertion?
 
As detailed earlier, TA proteins can translocate their COOH
terminus posttranslationally across the ER membrane, and
presumably across the MOM and choloroplast envelope as
well, although this has not been formally demonstrated so
far. Thus, an obvious question is whether the classical trans-
location machinery—the Sec61 translocon in the ER (Rapo-
port et al., 1996), the translocase of the outer mitochondrial
membrane (TOM; Neupert, 1997), and translocase of
the outer chloroplast membrane (Jarvis and Soll, 2002) sys-
tems for mitochondria and chloroplasts, respectively—are
involved.
Until recently, the possible involvement of Sec61 was ad-
dressed only in in vitro binding assays that did not follow
translocation of the COOH terminus of the analyzed pro-
tein. These studies yielded contradictory results, on the one
hand indicating that TA proteins could bind to Sec61-
depleted mammalian (Kutay et al., 1995) or yeast micro-
somes (Steel et al., 2002), on the other hand revealing a
weak cross-link between Sec61 and synaptobrevin at short
times after binding of this TA protein to microsomes (Abell
et al., 2003). In addition, it was found that synaptobrevin
binding to microsomes requires at least one trypsin-sensitive
component, different from Sec61 (Kutay et al., 1995). This
component, however, was not required by cytochrome b(5)
or Bcl-2 (Kim et al., 1997), suggesting that this or these un-
identified molecules may be specifically involved in the tar-
geting of subgroups of TA proteins.
We have recently reinvestigated the possible involvement
of Sec61 by applying to the yeast system a rigorous assay for
translocation, based on the in vivo utilization of an N-glyco-
sylation consensus sequence engineered to the COOH ter-
minus of mammalian cytochrome b(5) (Yabal et al., 2003).
Yeast strains defective in components of the Sec61 translo-
con or in accessory proteins involved in signal peptide-
driven co- or posttranslational translocation were tested for
their ability to glycosylate the COOH terminus of this b(5)
construct. None of the mutations or deletions had detect-
able effects on the in vivo translocation of b(5)’s tail, which
was rapidly glycosylated under conditions in which signal
peptide-driven posttranslocational translocation was abol-
ished. These results strongly suggest that translocation of TA
protein tails occurs by a mechanism not involving the Sec61
translocation machinery. This conclusion is nicely matched
by the observation that Sec61 function is also not required
for extraction from the membrane of another TA protein
(UBC6; Walter et al., 2001), a process that leads to protea-
 
somal degradation of ER proteins and that is generally based
on the retrotranslocational activity of Sec61p (Rapoport et
al., 1996). Nonetheless, the work of Yabal et al. (2003) does
not formally exclude that TA protein insertion occurs
through a novel function of the Sec61 translocon, not com-
promised by the numerous mutations analyzed in that
study. In either case, the results demonstrate the involve-
ment of a mechanism distinct from that of signal peptide–
driven posttranslational translocation, and set the stage for
research aimed at elucidating this mechanism.
For MOM-targeted TA proteins, in vitro experiments ad-
dressing the involvement of the TOM system have been per-
formed using two model proteins, Bcl-2 and VAMP IB. The
two proteins compete with each other for binding to the
MOM, but neither of them show impaired mitochondrial
association in the presence of matrix-directed preproteins
(Millar and Shore, 1996; Lan et al., 2000; Motz et al.,
2002). Conflicting results have been reported concerning
the trypsin sensitivity of the Bcl-2 binding sites on the mito-
chondrial surface (Nakai et al., 1993; Motz et al., 2002),
however an interaction between Bcl-2 and a glutathione
 
S
 
-transferase–TOM20 fusion protein has been reported
(Schleiff et al., 1997), and a recent paper has shown that
Bcl-2 binding to yeast mitochondria is partially dependent
on TOM20 (Motz et al., 2002). Interestingly, mutations in
other essential components of the TOM system were with-
out effect in this assay (Motz et al., 2002). Together, the re-
sults suggest that, as in the case of the ER, the MOM inser-
tion of TA proteins involves a novel mechanism that
deserves further study.
The energy requirements for membrane insertion have
also been investigated. ATP is required for the binding of
synaptobrevin I to microsomes (Kutay et al., 1995), and of
VAMP IB to mitochondria (Lan et al., 2000), but not for
the membrane association of cytochrome b(5) or Bcl-2 (Kim
et al., 1997). However, when bona fide translocation of
the COOH terminus of cytochrome b(5) was assayed (by
N-glycosylation of a COOH-terminal tag), a requirement for
low ATP concentrations was revealed (Yabal et al., 2003).
The ATP requirement for VAMP IB’s insertion into the
MOM has been reported to be related exclusively to chaper-
one function (Lan et al., 2000), and this could be the case
also for the other investigated proteins. Unfortunately, the
relevant chaperone(s) have not been identified so far, nor is
it known whether their function is limited to preventing the
aggregation of newly synthesized TA proteins, or whether
they are more specifically involved in guiding TA proteins to
the correct target membrane.
In conclusion, the available evidence suggests that the
classical import machinery of the ER and mitochondria do
not participate in the translocation of the COOH terminus
of TA proteins across the lipid bilayer. The specificity of the
targeting process does suggest that proteins are involved,
however differences in the lipid composition of the MOM
and the ER membrane (Colbeau et al., 1971) could also be
important. It is also conceivable that the targeting event re-
quires proteins, but that the subsequent translocation of the
COOH terminus occurs directly across the bilayer lipids of
the MOM and the ER membrane, whose lipid compositions
would be permissive for this event.T
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It may seem surprizing that a full 10 years after many of
the components of other translocation machines have been
identified, there is still so much ignorance on TA protein
translocation. This is partly because the realization that these
proteins undergo an interesting and unusual targeting and
translocation process was rather slow in coming, so that for
many years not much effort was devoted to them. In addi-
tion, because of the small number of residues that are trans-
located across the bilayer, a major difficulty has been in es-
tablishing appropriate assays to investigate TA protein
insertion. In our minds, the in vitro binding assays that have
generally been used may not be adequate and may yield re-
sults that do not report on the events occurring in vivo. In-
deed, tight binding of TA proteins to lipid bilayers without
translocation of the COOH terminus can occur in artificial
systems, as has been demonstrated for cytochrome b(5)
(Dailey and Strittmatter, 1981). Thus, requirements for in
vitro binding may not be the same as those for translocation
of the COOH terminus. For this reason, we feel that TA
protein insertion should be investigated using rigorous as-
says for COOH-terminal translocation. With this in mind,
it should be possible to devise genetic screens in yeast as well
as to conduct meaningful insertion studies in reconstituted
systems in vitro. It is hoped that a combination of genetic
and biochemical approaches will rapidly lead to the identifi-
cation of the molecular components required for TA protein
insertion, as occurred for other translocation systems some
years ago.
 
Regulation of TA protein localization
 
Because of its unusual features, TA protein insertion is a po-
tential target for novel regulatory mechanisms, and recent
research has revealed that regulation can indeed occur. Here,
we discuss two examples, both involving members of the
Bcl-2 family.
 
TA proteins can reside constitutively in the cytosol and
become integrated into a membrane in response to a sig-
nal. 
 
Although recruitment of peripheral proteins to the
plasma membrane is a well-established mechanism in signal-
ing pathways, the regulated integration of a transmembrane
protein into the bilayer is probably unique to TA proteins.
This phenomenon has been demonstrated for members of the
Bcl-2 family, but may turn out to be of general significance.
Proteins of the Bcl-2 family are key regulators of apopto-
sis, promoting either cell survival (e.g., Bcl-2 and Bcl-X
 
L
 
) or
programmed cell death (e.g., Bax, Bad, Bak). The exact
mechanisms by which these proteins work are debated (for
review see Cory and Adams, 2002), but it is widely believed
that oligomers of proapoptotic members contribute to the
MOM permeabilization that allows efflux of apoptogenic
proteins from the intermembrane space. The prosurvival
members would have the opposite effect, antagonizing the
proapoptotic members and preserving the MOM permeabil-
ity barrier.
Most members of the Bcl-2 family are TA proteins, of
which some reside in the cytosol and translocate to the
MOM in response to an apoptogenic signal. Of these,
proapoptotic Bax is the best studied example. In healthy
cells, Bax resides in the cytosol in soluble, monomeric form.
Early during apoptosis, Bax translocates from the cytosol to
mitochondria where it disrupts the MOM permeability
barrier (for review see Cory and Adams, 2002). Determina-
tion of the structure of Bax in solution has revealed that
its  COOH-terminal tail occupies a hydrophobic pocket
thought to provide a binding site for the so-called BH3 do-
main of Bcl-2 family members that switch on the proapop-
totic activity of Bax (Suzuki et al., 2000). Thus, displace-
ment of the COOH-terminal region from the BH3 binding
pocket, in addition to allowing the tail to interact with the
MOM, could also promote dimer formation.
The sequence requirements for the regulated integration
of Bax into the MOM have been investigated (Nechushtan
et al., 1999). Essential for the regulated binding of Bax to
the MOM is a Ser residue toward the end of the putative
TMD (Ser184). When this residue is either deleted or re-
placed with Val or Ala, Bax constitutively localizes to the
MOM. Moreover, the mutated tail region of Bax is suffi-
cient to target a reporter (GFP) to the MOM. In contrast,
GFP carrying the wild-type Bax tail remains cytosolic and is
incapable of relocating to the MOM in response to an apop-
togenic signal. Structural studies (Suzuki et al., 2000) re-
vealed that an H-bond between Ser184 and Asp98 stabilizes
the binding of the COOH-terminal tail in the hydrophobic
pocket, explaining why deletion or substitution of this resi-
due leads to dissociation of the tail, and subsequent integra-
tion into the MOM. However, it remains unclear why the
wild-type tail, when appended to a reporter protein, does
not associate with the MOM. Moreover, the nature of the
stimulus causing the conformational switch that leads BAX
to insert into the MOM is presently not understood. Given
the wide interest in proteins of the Bcl-2 family, it is hoped
that the exact events that trigger Bax’s conformational
switch will soon be discovered.
 
The distribution of TA proteins between the ER and the
MOM might be regulated. 
 
As detailed earlier, upon release
from ribosomes, TA proteins are targeted to a small subset of
intracellular membranes, comprising the ER, the MOM,
and, in plants, the plastid membrane. In a study aimed at
elucidating the relation between ER and MOM targeting,
we used a MOM-localized form of cytochrome b(5) modi-
fied to carry an N-glycosylation site close to the COOH ter-
minus, as reporter for transit through the ER (Borgese et al.,
2001). In vitro, this construct was capable of translocating
its COOH terminus across ER microsomes, as demon-
strated by the efficient utilization of the N-glycosylation
consensus site. In vivo, however, it was targeted nearly exclu-
sively to mitochondria and was not glycosylated, indicating
that it did not transit through the ER. Thus, notwithstand-
ing its full competence to insert into ER membranes, when
faced with a choice in vivo, this protein preferred the MOM,
suggesting that ER and MOM are in competition for TA
proteins. This phenomenon could explain the dual MOM/
ER localization of some TA proteins (Fig. 2). In addition,
the outcome of the competition could well be modulated,
for instance, by alteration of the chaperone repertoire within
the cell or by posttranslational modifications of the TA pro-
tein itself. Such a regulated change of the target membrane
could have important functional consequences.
An example of how localization and function of TA pro-
teins could be modulated is offered by the antiapoptotic pro-T
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tein Bcl-2. Bcl-2 is targeted both to the ER and to the
MOM, and association with membranes is required for its
biological activity (for review see Cory and Adams, 2002).
Studies with chimaeras have demonstrated that its mem-
brane localization is mediated by the tail region (Nguyen et
al., 1993), as is generally the case with TA proteins. In addi-
tion, interactions of the NH
 
2
 
-terminal domain with a
MOM-localized binding partner (FKB38) increase its mito-
chondrial localization (Shirane and Nakayma, 2003). Stud-
ies with forms of Bcl-2 engineered to localize exclusively to
the ER or to the MOM have shown that in the two localiza-
tions it has different functions (Cory and Adams, 2002).
More specifically, the ER associated form has been impli-
cated in the maintenance of calcium homeostasis (He et al.,
1997) and, although protective against a limited subset of
apoptogenic signals, may in some cases be more effective
than the MOM targeted protein. Thus, modulation of the
targeting of Bcl-2, for instance by varying the expression lev-
els of FKB38 (Shirane and Nakayma, 2003), could finetune
the cell’s response to death and survival signals.
 
Conclusions and perspectives
 
10 years ago a short review (Kutay et al., 1993) raised a
number of questions on TA protein targeting and traffick-
ing, for some of which we have clear answers today. As sum-
marized in this review, we now know that the COOH ter-
minus can be translocated across the bilayer, that these
proteins are specifically targeted to a small subset of intracel-
lular membranes, that the hydrophobic anchor plays a key
role in targeting and trafficking to different organelles, and
that insertion into the ER occurs via a novel mechanism
probably not involving the classical translocation machinery.
In addition, it has become apparent that TA protein target-
ing and insertion can be regulated, a finding that increases
the interest in the mechanisms of localization of these pro-
teins, many of which are key players in fundamental pro-
cesses within cells. Nonetheless, the central issue of the na-
ture of the molecules involved in TA protein insertion has
not been resolved yet. Given the recent increased interest in
TA proteins, it is hoped that answers to this question will be
coming soon, opening the way to unravel novel modes of
regulated trafficking of this class of membrane proteins.
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